• Nebius Group has recently unveiled a £1.70 billion UK AI infrastructure build-out across three NVIDIA-powered sites and, alongside NVIDIA, launched a Physical AI Living Lab to give European robotics startups access to advanced simulation tools and Nebius’s AI cloud platform.
• These moves deepen Nebius’s role in AI infrastructure while pulling it closer to real-world robotics deployment, potentially widening its reach across Europe’s physical AI and research ecosystems.
• We’ll now examine how Nebius’s large UK infrastructure expansion and new NVIDIA-backed Physical AI Living Lab reshape its investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 48 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Nebius Group Investment Narrative Recap

To own Nebius, you need to believe that hyperscale AI infrastructure can justify heavy capital spending and a rich valuation, even with intense competition and volatile sentiment. Right now, the key near term catalyst is continued AI cloud adoption and capacity ramp, while the biggest risk is overbuilding expensive sites if demand or pricing weakens. The UK build-out and Physical AI Living Lab reinforce Nebius’s AI focus, but do not fundamentally change that risk profile in the short term.

Among recent developments, Nebius’s addition to the Nasdaq 100 from 22 June 2026 stands out. Index inclusion often increases visibility and can pull in forced buying from index trackers, intersecting directly with the current share price run-up and high expectations. Against that backdrop, the £1.70 billion UK expansion and NVIDIA-backed Living Lab arrive at a time when expectations are already elevated, sharpening the risk if execution or AI spending were to slow.

Yet beneath the excitement around UK expansion, investors should be aware that Nebius’s capital intensity and the risk of overbuilding at premium valuations could...

Nebius Group's narrative projects $24.1 billion revenue and $378.3 million earnings by 2029. This requires 201.8% yearly revenue growth and a $357.0 million earnings decrease from $735.3 million today.

Uncover how Nebius Group's forecasts yield a $238.86 fair value, a 3% upside to its current price.

Exploring Other Perspectives

More bullish analysts already expected Nebius to reach about US$44.0 billion in revenue and US$1.8 billion in earnings, so this UK news could either support that optimistic expansion story or highlight how much those forecasts depend on everything going right.

Explore 14 other fair value estimates on Nebius Group - why the stock might be worth as much as 25% more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Nebius Group research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Nebius Group research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Nebius Group's overall financial health at a glance.

Looking For Alternative Opportunities?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Find 44 companies with promising cash flow potential yet trading below their fair value.
• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Explore 29 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.